NDTV News

NDTV.com provides latest news from India and the world. Get today’s news headlines from Business, Technology, Bollywood, Cricket, videos, photos, live news coverage and exclusive breaking news from India.

https://www.ndtv.com/

Anti-Covid Drug Trial Shows «Robust Efficacy» : AstraZeneca.

Anti-Covid Drug Trial Shows 'Robust Efficacy': AstraZeneca

AstraZeneca has already submitted an application to US regulators for approval of its Covid drug (File)

London:

Pharmaceutical giant AstraZeneca on Thursday announced that clinical trials of an antibody-based COVID-19 drug had shown robust efficacy and long-term prevention.

The Anglo-Swedish laboratory follows in the footsteps of US firms Merck and Pfizer, which announced in October and early November respectively that they had developed drugs that could prevent severe forms of the disease, and that could be taken at the first sign of symptoms.

The AstraZeneca drug AZD7442, made from a combination of two antibodies, has been undergoing final stage clinical trials to assess its safety and efficacy.

A six-month follow-up trial "showed robust efficacy from a one-time intramuscular (IM) dose of the long-acting antibody (LAAB) combination", it said in a statement.

One 300mg IM dose reduced the risk of developing symptomatic COVID-19 compared to placebo by 83 percent, it added.

More than 75 per cent of participants had co-morbidities that put them at high risk for severe COVID-19 if they were to become infected, but no severe cases were recorded.

Another trial to test its efficacy in treating those already suffering from "mild to moderate" Covid symptoms showed that one 600mg IM dose reduced the risk of developing severe illness or death by 88 percent.

"These compelling results give me confidence that this long-acting antibody combination can provide my vulnerable patients with the long-lasting protection they urgently need to finally return to their everyday lives," said Hugh Montgomery, professor of intensive care medicine at University College London.

"Importantly, six months of protection was maintained despite the surge of the Delta variant among these high-risk participants who may not respond adequately to vaccination."

AstraZeneca said the full results of both trials would be submitted for publication to a peer-reviewed medical journal.

It has already submitted an application to US regulators for approval of the drug to treat COVID-19.

AstraZeneca's separate Covid vaccine, developed with the University of Oxford, helped enable Britain's speedy Covid vaccination drive after it was approved in December 2020.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

Related news
'The Five' slam media's defense of Biden's COVID failures.

'The Five' slam media's defense of Biden's COVID failures.

'The Five' panel reacts to the president's remarks that COVID has become 'politicized' #FoxNews #TheFive Subscribe to Fox News! Watch more Fox News Video: Watch Fox News Channel Live: FOX News Channel (FNC) is a 24-hour all-encompassing news servi...

California teachers recruit students to gay club behind parents' backs.

California teachers recruit students to gay club behind parents' backs.

'Irreversible Damage' author Abigail Shrier shares details on how students are being lured into joining school clubs that explore sexuality. #FoxNews #TuckerCarlsonTonight Subscribe to Fox News! Watch more Fox News Video: Watch Fox News Channel Li...

NYC Woman That Drove Through BLM Protest Goes To Court.

NYC Woman That Drove Through BLM Protest Goes To Court.

Kathleen Casillo who drove through a Black Lives Matter protest in Manhattan and injured multiple people rejected a sentencing deal and now faces jail time. NBC News' Vaughn Hillyard reports. » Subscribe to NBC News: » Watch more NBC video: NBC Ne...

Michigan school shooting survivor remembers the victims: We are one family.

Michigan school shooting survivor remembers the victims: We are one family.

Oxford High School student Javon Pittman and family speak out on the ‘heartache’ following the tragedy on ‘The Story.’ #FoxNews #TheStory Subscribe to Fox News! Watch more Fox News Video: Watch Fox News Channel Live: FOX News Channel (FNC) is a 24...

1 25

Epstein's Former House Manager Testifies In Ghislaine Maxwell Trial.

Epstein's Former House Manager Testifies In Ghislaine Maxwell Trial.

In court, former Jeffrey Epstein house manager Juan Alessi called Ghislaine Maxwell the "Lady of the House." The prosecution alleges Maxwell lured underage girls for Epstein to abuse. NBC News' Stephanie Gosk has more. » Subscribe to NBC News: » W...

Graham: Biden's Build Back Better will destroy energy production if it becomes law.

Graham: Biden's Build Back Better will destroy energy production if it becomes law.

South Carolina Republican reacts to the Democrats' hiding the real cost of Biden's spending agenda on 'Hannity' #FoxNews #Hannity Subscribe to Fox News! Watch more Fox News Video: Watch Fox News Channel Live: FOX News Channel (FNC) is a 24-hour al...